HUT52958A - Process for production of medical compositions assuring the constant release of the active substance - Google Patents

Process for production of medical compositions assuring the constant release of the active substance

Info

Publication number
HUT52958A
HUT52958A HU874311A HU431187A HUT52958A HU T52958 A HUT52958 A HU T52958A HU 874311 A HU874311 A HU 874311A HU 431187 A HU431187 A HU 431187A HU T52958 A HUT52958 A HU T52958A
Authority
HU
Hungary
Prior art keywords
assuring
production
active substance
constant release
medical compositions
Prior art date
Application number
HU874311A
Other languages
Hungarian (hu)
Other versions
HU201875B (en
Inventor
Gan Henry C
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of HUT52958A publication Critical patent/HUT52958A/en
Publication of HU201875B publication Critical patent/HU201875B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
HU874311A 1986-10-09 1987-09-25 Process for producing retarde pharmaceutical compositions containing acetyl-salicylic acid HU201875B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868624213A GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions

Publications (2)

Publication Number Publication Date
HUT52958A true HUT52958A (en) 1990-09-28
HU201875B HU201875B (en) 1991-01-28

Family

ID=10605478

Family Applications (1)

Application Number Title Priority Date Filing Date
HU874311A HU201875B (en) 1986-10-09 1987-09-25 Process for producing retarde pharmaceutical compositions containing acetyl-salicylic acid

Country Status (24)

Country Link
JP (1) JPS63101334A (en)
KR (1) KR880004801A (en)
AU (1) AU7942087A (en)
BE (1) BE1000732A5 (en)
CA (1) CA1332809C (en)
CH (1) CH675831A5 (en)
DE (1) DE3733540A1 (en)
DK (1) DK527487A (en)
ES (1) ES2014518A6 (en)
FI (1) FI874414A (en)
FR (1) FR2604902B1 (en)
GB (2) GB8624213D0 (en)
GR (1) GR871550B (en)
HU (1) HU201875B (en)
IL (1) IL84104A0 (en)
IT (1) IT1221493B (en)
LU (1) LU87009A1 (en)
NL (1) NL8702294A (en)
NO (1) NO874200L (en)
NZ (1) NZ222083A (en)
PH (1) PH24227A (en)
PT (1) PT85880B (en)
SE (1) SE8703889L (en)
ZA (1) ZA877617B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
EP1649851B1 (en) * 1999-03-31 2018-06-20 Janssen Pharmaceutica NV Pregelatinized starch in a controlled release formulation
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
SE0102887D0 (en) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102886D0 (en) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102888D0 (en) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
PL1803447T3 (en) * 2004-09-09 2010-05-31 Psicofarma S A De C V Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795766A (en) * 1972-02-22 1973-08-22 Lilly Co Eli PROPOXYPHENE DELAY NAPSYLATE PARTICLES AND PROCESS FOR MANUFACTURING SUCH PARTICLES
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
DE3346571A1 (en) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen ORAL RETARDED ACETYLSALICYL ACID FORMULATIONS
AU4064285A (en) * 1984-03-21 1985-10-11 American Home Products Corporation Sustained release pharmaceutical capsules

Also Published As

Publication number Publication date
SE8703889L (en) 1988-04-10
DE3733540A1 (en) 1988-04-14
GB8723515D0 (en) 1987-11-11
CA1332809C (en) 1994-11-01
NL8702294A (en) 1988-05-02
FR2604902B1 (en) 1991-04-26
PT85880B (en) 1990-07-31
IL84104A0 (en) 1988-03-31
FR2604902A1 (en) 1988-04-15
GB2195893A (en) 1988-04-20
CH675831A5 (en) 1990-11-15
DK527487D0 (en) 1987-10-08
NO874200L (en) 1988-04-11
GB2195893B (en) 1991-05-08
IT8748469A0 (en) 1987-10-08
AU7942087A (en) 1988-04-14
FI874414A (en) 1988-04-10
PT85880A (en) 1987-11-01
DK527487A (en) 1988-04-10
GR871550B (en) 1988-02-15
LU87009A1 (en) 1988-05-03
HU201875B (en) 1991-01-28
ES2014518A6 (en) 1990-07-16
NO874200D0 (en) 1987-10-07
SE8703889D0 (en) 1987-10-08
GB8624213D0 (en) 1986-11-12
KR880004801A (en) 1988-06-27
IT1221493B (en) 1990-07-06
BE1000732A5 (en) 1989-03-21
NZ222083A (en) 1991-05-28
JPS63101334A (en) 1988-05-06
PH24227A (en) 1990-05-04
FI874414A0 (en) 1987-10-07
ZA877617B (en) 1989-05-30

Similar Documents

Publication Publication Date Title
PT83756A (en) Process for the manufacture of controlled release pharmaceutical compositions
PT85521A (en) Process for the preparation of pharmaceutical compositions com-prising microcapsules
HUT47022A (en) Process for production of medical compositions
HUT50152A (en) Process for production of derivatives of benzopiran and medical compositions containing them as active substance
HUT45895A (en) Process for production of serotomin antagonic compounds and medical preparatives containing such compositions
HUT47561A (en) Process for production of 3-aryloxi-3-substituated propanamids and medical compositions containing them
HUT44489A (en) Process for production of derivatives of benzosulphonamid-indanyl and medical preparatives containing them as active substance
HUT46912A (en) Process for production of 1,4-dihydro-piridines and medical preparatives containing such compositions
ZA871657B (en) Process for the preparation of medicament adsorbates
HUT49494A (en) Process for producing active component of pharmaceutical compositions
HUT51596A (en) Process for production of the active substance of the medical composition levodopa
HUT50166A (en) Process for production of substituated 3,4-dihydro-rh-benzopiranes and medical compositions containing them
HU9200821D0 (en) Process for the production of medical preparation containing tioredoxine
HUT52958A (en) Process for production of medical compositions assuring the constant release of the active substance
HU9201706D0 (en) Process for the production of oxazole derivatives and medical preparation containing them as active agents
HUT49807A (en) Process for production of medical compositions and the active substance
HUT45268A (en) Process for production of tripeptide-agregations and medical preparatives containing them as active substance
HUT50762A (en) Process for production of medical compositions containing as active substance derivatives of pirrol and process for production of the active substance
HUT45972A (en) Process for production of derivatives of subsituated amin-methil-5,6,7,8-tetrahydronaphtil-oxi-acetic acid, of medical compositions containing such substances and also of the intermediers
HUT50157A (en) Process for production of 1,3-dioxane and medical compositions containing them as active substance
HUT45018A (en) Process for production of rapamicine-derivatives and medical compositions containing them as active substance
PT86297A (en) Process for preparing aryloxybenzeneacetic acid derivatives and of pharmaceutical compositions containing the same
PT84466B (en) Process for preparing aryl-azolylmethyl-benzocycloalkene derivatives and of pharmaceutical and fungicidal compositions containing the same
HUT44018A (en) Insecticides and acaricides containing as active substance 5-amin-1-phenil-pirasole derivatives and process for production of the active substances
HUT50180A (en) Process for production of derivatives of 2,3,4,5,6,7-hexahydro-2,7-methan-1,5-benzoxasonine or 1,4-benzoxasonine and medical compositions containing them

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee